Labiana Health S.A. (LAB) — Capital Reinvestment Ratio
Latest as of December 2022:
1.17x
Labiana Health S.A. (LAB) has a Capital Reinvestment Ratio of 1.17x as of December 2022, meaning it reinvests 1% of its operating cash flow (€4.68 Million) in capital expenditures (€5.45 Million). See LAB cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.17x
Capex / Operating Cash Flow
Operating Cash Flow
€4.68 Million
EUR
Capital Expenditures
€5.45 Million
EUR
Data as of
Dec 2022
Most recent filing
Labiana Health S.A. Capital Reinvestment Ratio (2021–2024)
This chart tracks Labiana Health S.A.'s Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Labiana Health S.A. (2021–2024)
Year-by-year Capital Reinvestment Ratio for Labiana Health S.A. from 2021 to 2024. For live market cap and broader valuation context, see LAB market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | €7.19 Million | €3.05 Million | ▼ -63.7% |
| 2022 | 1.17x | €4.68 Million | €5.45 Million | ▼ -4.5% |
| 2021 | 1.22x | €3.91 Million | €4.77 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow